Current status of cell-based therapies for respiratory virus infections: applicability to COVID-19
Current status of cell-based therapies for respiratory virus infections

Abstract
The severe respiratory consequences of the coronavirus disease 2019 (COVID-19) pandemic have prompted urgent need for novel therapies. Cell-based approaches, primar